Cambridge Innovation Capital — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Inivatainivata.comMay 2020 · $7M

BiotechCambridge

Jeffrey Buchalter(Director)Clive Morris(Executive Officer, Director)Peter Wright-Smith(Director)Douglas M. VanOrt(Director)Timothy Shannon(Executive Officer)

Board seatRobert Tansley· per SEC Form D

Co-investorsFuture Planet Capital Rosetta Capital Ltd.

Congenicacongenica.comSeries B · Nov 2020 · $50M

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsFuture Planet Capital QVentures Xeraya Capital Amadeus Capital Partners IDO Investments Legal & General +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.